World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
43261
World Ranking
12450
National Ranking
386

Alfred Mahr publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alfred Mahr sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 334 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alfred Mahr D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alfred Mahr sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alfred Mahr is affiliated with Université Paris Cité in France and has made substantial contributions to medical research, focusing primarily on rheumatology and related fields. Their work spans various subfields including pulmonary and respiratory medicine, genetics, ophthalmology, and surgery. The main focus lies in the study of vasculitis and associated conditions, supported by extensive publications in these areas.

The scientist's research involves a wide range of topics, with particular concentration on:

  • Vasculitis and related conditions
  • Otitis Media and Relapsing Polychondritis
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Ocular Diseases and Behçet's Syndrome
  • Urticaria and Related Conditions
  • Eosinophilic Disorders and Syndromes
  • Heparin-Induced Thrombocytopenia and Thrombosis

Mahr's recent papers demonstrate active engagement with key medical debates and clinical guidelines. Notable publications include:

  • "2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides," 2020, UNC Libraries
  • "EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update," 2023, Annals of the Rheumatic Diseases
  • "Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis," 2023, Nature Reviews Rheumatology
  • "British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis," 2020, Lara D. Veeken
  • "British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary," 2020, Lara D. Veeken

The scholar frequently collaborates with other experts in the field, including:

  • David Jayne
  • Peter A. Merkel
  • María C. Cid
  • Thomas Neumann
  • Augusto Vaglio

The majority of Mahr's publications are found in several key venues that reflect their specialized research interests. These include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Nephrology Dialysis Transplantation
  • Seminars in Arthritis and Rheumatism
  • UNC Libraries

With over 140 publications in medicine, Alfred Mahr's profile indicates a strong emphasis on clinical and translational research within rheumatology-related disciplines.

Best Publications

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu

  • Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

    Richard Watts;Suzanne Lane;Thomas Hanslik;Thomas Hauser

  • EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

    M. Yates;M. Yates;R. A. Watts;I. M. Bajema;M. C. Cid

  • Revised international Chapel Hill consensus conference nomenclature of vasculitides

    J. C. Jennette;R. J. Falk;P. Bacon;N Basu

  • Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

    Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra

  • Long-term patient survival in ANCA-associated vasculitis

    Oliver Flossmann;Annelies Berden;Kirsten de Groot;Chris Hagen

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier

  • The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.

    Loïc Guillevin;Christian Pagnoux;Raphaele Seror;Alfred Mahr

  • 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

    Bernhard Hellmich;Ana Agueda;Sara Monti;Frank Buttgereit

  • Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

    Ronald J. Falk;Wolfgang L. Gross;Loïc Guillevin;Gary S. Hoffman

  • Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome

    Régis Sablé-Fourtassou;Pascal Cohen;Alfred Mahr;Christian Pagnoux

  • EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

    Bernhard Hellmich;Oliver Flossmann;Wolfgang L Gross;Paul Bacon

  • Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

    Alfred D. Mahr;Juan A. Jover;Robert F. Spiera;César Hernández-García

  • Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate.

    Alfred Mahr;Loïc Guillevin;Marc Poissonnet;Ségolène Aymé

  • Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

    Christian Pagnoux;Alfred Mahr;Mohamed A. Hamidou;Jean-Jacques Boffa

  • Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

    Thomas F. Hiemstra;Michael Walsh;Alfred Mahr;Caroline O. Savage

  • 2018 update of the EULAR recommendations for the management of Behçet’s syndrome

    Gulen Hatemi;Robin Christensen;Dongsik Bang;Bahram Bodaghi

  • Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database

    Christian Pagnoux;Raphaèle Seror;Corneliu Henegar;Alfred Mahr

  • HLA–B51/B5 and the Risk of Behçet’s Disease: A Systematic Review and Meta-Analysis of Case–Control Genetic Association Studies

    Mathilde de Menthon;Michael P. LaValley;Carla Maldini;Loïc Guillevin

  • Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

    Thomas F. Hiemstra;Michael Walsh;Alfred Mahr;Caroline O. Savage

Frequent Co-Authors

Loïc Guillevin
Loïc Guillevin Université Paris Cité
Raashid Luqmani
Raashid Luqmani University of Oxford
David Jayne
David Jayne University of Cambridge
Luc Mouthon
Luc Mouthon Université Paris Cité
Ulrich Specks
Ulrich Specks Mayo Clinic
Xavier Puéchal
Xavier Puéchal Université Paris Cité
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
Richard A. Watts
Richard A. Watts University of East Anglia
Maria C. Cid
Maria C. Cid University of Barcelona
Olivier Fain
Olivier Fain Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options related to Medicine in the USA opens up a range of online degree opportunities beyond the traditional MD or DO path. For registered nurses seeking to advance their careers quickly, adn to fnp bridge programs allow professionals to earn advanced practice credentials while continuing to work.

If you are interested in the science of human nutrition and wellness, earning a nutritionist online degree lets you build a foundation for a career in dietetics and community health, with flexible study options.

For those interested in healthcare leadership, it’s vital to know how to evaluate healthcare administration degree programs. Accreditation, online support services, and career resources can play a significant role in your education and future job prospects.

Finally, nurses looking to advance from RN credentials should consider whether their pathway requires hands-on experience. Discover the options available—some does rn to bsn require clinicals—to ensure the program matches your lifestyle and career goals.

Best Scientists Citing Alfred Mahr

Trending Scientists

Recently Published Articles